| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PENTRACOR Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 29,200 | +1,88 % | Hims & Hers announces departure of chief accounting officer who helped through its IPO | ||
| NUGEN MEDICAL DEVICES | 0,011 | -11,48 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| AFFINOR GROWERS | 0,016 | +29,17 % | XFRA 1AF0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ADVANCED BIOMED | 9,000 | +1,12 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,54 | +0,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 26,260 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,340 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,090 | -0,05 % | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | ||
| BILLIONTOONE | 125,20 | +0,05 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,650 | +0,83 % | BERNSTEIN RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung von Fresenius Medical Care (FMC) mit "Market-Perform" und einem Kursziel von 44,65 Euro gestartet. Mit der Markteinführung... ► Artikel lesen | |
| FRESENIUS | 43,010 | +0,75 % | Fresenius: Analystenlob sorgt für neuen Schwung - Trading-Tipp des Tages | Die Aktie von Fresenius hat nach einer weitestgehend enttäuschenden ersten Jahreshälfte 2026 ab Juni wieder Fahrt aufgenommen. Nach einem kleinen Rücksetzer sorgen die Analysten der Deutschen Bank für... ► Artikel lesen | |
| GENEDX | 60,73 | +0,13 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| SIEMENS HEALTHINEERS | 34,770 | -1,17 % | ANALYSE-FLASH: UBS belässt Siemens Healthineers auf 'Neutral' - Ziel 38 Euro | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 38 Euro auf "Neutral" belassen. In der Radiotherapie heiße es nicht mehr nur... ► Artikel lesen |